<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001783</url>
  </required_header>
  <id_info>
    <org_study_id>980115</org_study_id>
    <secondary_id>98-N-0115</secondary_id>
    <nct_id>NCT00001783</nct_id>
  </id_info>
  <brief_title>Motor Recovery in Recent Stroke Patients Treated With Amphetamine and Physical Therapy</brief_title>
  <official_title>Neuroanatomical and Neurophysiological Basis of Motor Recovery Associated With Treatment of Recent Stroke Using Amphetamine and Physical Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if giving amphetamines along with standard&#xD;
      rehabilitation speeds motor recovery after a stroke. In addition, if motor recovery is&#xD;
      improved, the study will also identify the areas of the brain involved with the recovery.&#xD;
&#xD;
      Researchers will use motor function ratings, PET scans, functional MRI (fMRI),&#xD;
      electroencephalographs, and transcranial magnetic stimulation (TMS) to evaluate patients.&#xD;
&#xD;
      Patients participating in the study will be placed in one of two groups;&#xD;
&#xD;
        1. Patients receiving dextroamphetamine and routine Rehabilitation Medicine&#xD;
&#xD;
        2. Patients receiving a placebo &quot;sugar pill&quot; and routine Rehabilitation Medicine&#xD;
&#xD;
      Patients that have improved motor recovery will undergo neuroimaging and neurophysiological&#xD;
      studies to identify areas of the brain involved.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine if administration of dextroamphetamine (amph)&#xD;
      linked with customarily used Rehabilitation Medicine accelerates motor recovery after stroke.&#xD;
      Additionally, if motor recovery occurs, this study will allow identification of the brain&#xD;
      regions activated in association with this recovery.&#xD;
&#xD;
      Techniques used will include longitudinal rating of motor function, neuro-imaging with&#xD;
      positron emission tomography (PET) and functional magnetic resonance tomography (fMRI),&#xD;
      electroencephalography (EEG) and transcranial magnetic stimulation (TMS). Patients will be&#xD;
      assigned to one of the two groups: amph linked with PT, and placebo linked with PT. Every&#xD;
      patient will receive the standard of care PT. Motor recovery will be evaluated in the two&#xD;
      groups. If motor recovery is accelerated in any of the groups, then neuroimaging and&#xD;
      neurophysiological data will allow identification of areas and networks in the brain&#xD;
      associated with this recovery.&#xD;
&#xD;
      This is a Phase II study with potential major impact on how stroke patients are treated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 1998</start_date>
  <completion_date>June 2004</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <enrollment>34</enrollment>
  <condition>Cerebrovascular Accident</condition>
  <condition>Paralysis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0-15 Water</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA:&#xD;
&#xD;
        Hemiparetic patients (right or left) (defined as a score of 55 or lower on Fugl-Meyer&#xD;
        Scale) who had a single thromboembolic non-hemorrhagic infarction (documented by CT or MRI)&#xD;
        5 to 30 days before.&#xD;
&#xD;
        Patients will be recruited from referrals from the community particularly from Suburban&#xD;
        Hospital.&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
        Large hemorrhagic or brain stem stroke.&#xD;
&#xD;
        Multiple cerebral lesions with residual deficits.&#xD;
&#xD;
        Less than 5 days after stroke or greater than 30 days after stroke.&#xD;
&#xD;
        Age younger than 18 or older than 80 years.&#xD;
&#xD;
        History of head injury with loss of consciousness.&#xD;
&#xD;
        Terminal illness such as AIDS or cancer.&#xD;
&#xD;
        Severe neurological diseases other than stroke.&#xD;
&#xD;
        History of severe alcohol or drug abuse.&#xD;
&#xD;
        History of psychiatric illness.&#xD;
&#xD;
        Unstable cardiac dysrhythmia or unresponsive arterial hypertension (greater than 160/100&#xD;
        mmHg).&#xD;
&#xD;
        Untreated hyperthyroidism.&#xD;
&#xD;
        Receiving alpha-adrenergic antagonists or agonists.&#xD;
&#xD;
        Receiving major/minor tranquilizers, clonidine, prazosin, phenytoin, GABA, benzodiazepines,&#xD;
        scopolamine, haloperidol, other neuroleptics, barbituates.&#xD;
&#xD;
        Degree of aphasia or cognitive deficit that makes patients unable to give informed consent.&#xD;
&#xD;
        Pregnancy. A pregnancy test will be done on admission.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Institute of Neurological Disorders and Stroke (NINDS)</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science. 1982 Aug 27;217(4562):855-7. doi: 10.1126/science.7100929.</citation>
    <PMID>7100929</PMID>
  </reference>
  <reference>
    <citation>Crisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol. 1988 Jan;23(1):94-7. doi: 10.1002/ana.410230117.</citation>
    <PMID>3345072</PMID>
  </reference>
  <reference>
    <citation>Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke. 1995 Dec;26(12):2254-9. doi: 10.1161/01.str.26.12.2254.</citation>
    <PMID>7491646</PMID>
  </reference>
  <verification_date>June 2004</verification_date>
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>November 3, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 1999</study_first_posted>
  <last_update_submitted>March 3, 2008</last_update_submitted>
  <last_update_submitted_qc>March 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2008</last_update_posted>
  <keyword>Rehabilitation</keyword>
  <keyword>Plasticity</keyword>
  <keyword>Stroke</keyword>
  <keyword>Amphetamine</keyword>
  <keyword>Motor</keyword>
  <keyword>Hemiparetic</keyword>
  <keyword>Thromboembolic Non-Hemorrhagic Infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Paralysis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

